Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

11/7/2012 (2 years ago)

Catholic Online (www.catholic.org)

Seralaxin reports high success rate in patients

An experimental drug, called serelaxin from the Novartis AG drug group to treat hospitalized acute heart failure patients has reported remarkable success. The death rate was decreased by as much as 37 percent compared with a placebo and appeared to be safe.

Novartis says that it now seeks approval for serelaxin. Researchers say that in a study of 1,161 patients, the drug cut deaths from any cause at six months by 37 percent and led to a marked reduction in worsening of heart failure during hospitalization.

Novartis says that it now seeks approval for serelaxin. Researchers say that in a study of 1,161 patients, the drug cut deaths from any cause at six months by 37 percent and led to a marked reduction in worsening of heart failure during hospitalization.

Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

11/7/2012 (2 years ago)

Published in Health

Keywords: Serelaxin, heart failure, mortality rate, shortness of breath


LOS ANGELES, CA (Catholic Online) - According to data from a late stage clinical trial presented this week, serelaxin, a form of a human hormone that relaxes blood vessels and eases stress on the heart and other organs, is now considered one of the most important medicines in the Swiss drug maker's developmental pipeline.

"With a meaningful mortality benefit, we believe Serelaxin could represent a $2.5 billion (annual) sales opportunity," Deutsche Bank analysts said.

Novartis says that it now seeks approval for serelaxin. Researchers say that in a study of 1,161 patients, the drug cut deaths from any cause at six months by 37 percent and led to a marked reduction in worsening of heart failure during hospitalization.

In fact, patients that received 48 hours of continuously infused serelaxin experienced more than 45 percent fewer episodes of worsening heart failure symptoms than those treated with a placebo.

Novartis had previously disclosed that serelaxin met one of the study's two primary goals measuring relief of dyspnea, or extreme shortness of breath, which is a common symptom of acute heart failure. By one measure, serelaxin led to a 19 percent improvement in dyspnea, researchers said.

The drug failed to hit a secondary goal of the study that combined cardiovascular death with need for re-hospitalizations. Researchers feel that the life saving benefit is far more important.

"We did have a startling death benefit. One of the reasons there may have been an inability to show a decrease in hospitalizations is more patients was alive to be re-hospitalized," Dr. John Teerlink, one of the trial's co-lead researchers says. A cardiologist and heart failure specialist at the San Francisco VA Medical Center says that the data showed that only 29 acute heart failure patients would have to be treated with serelaxin to prevent one cardiovascular death.

There is a pressing need for a treatment for acute heart failure, with few available options for the condition in which the heart is unable to pump enough blood.

"If it was approved we would not only use it, there would be a mandate to use it because we don't have anything for acute decompensated heart failure," Dr. Milton Packer, a prominent cardiologist from the University of Texas says.

While he was not part of the study, Packer is excited about the possibilities presented by the new drug. "If that mortality finding is real, boy, are we going to get excited!"

There are more than one million hospitalizations in the United States each year for acute heart failure and another million in Europe.

.

---


Pope Francis: end world hunger through 'Prayer and Action'


Copywriter 2015 - Distributed by THE NEWS CONSORTIUM

Pope Francis Prayer Intentions for July 2015
Universal:
That political responsibility may be lived at all levels as a high form of charity.
Evangelization: That, amid social inequalities, Latin American Christians may bear witness to love for the poor and contribute to a more fraternal society.



Comments


More Health

8-year-old boy becomes youngest double-hand transplant patient Watch

Image of

By Talia Ramos (NEWS CONSORTIUM)

Surgeons believe 8-year-old Zion Harvey is the youngest to receive a double-hand transplant. The boy lost both of his hands over a severe infection years ago and opted to go through a transplant with the support of his parents. After the initial success of the ... continue reading


World's first malaria vaccine wins approval from European drug regulators Watch

Image of Mosquirix must first win agreement from African governments as the vaccine only offers only partial protection.

By Catholic Online (NEWS CONSORTIUM)

The world's first malaria vaccine is a go with European drug regulators after it was recommended safe and effective for babies at risk of the 'mosquito-born disease' in Africa. LOS ANGELES, CA (Catholic Online) - Called Mosquirix, the vaccine was developed by ... continue reading


560-pound man sets out to bike across the U.S. to lose weight and save his marriage Watch

Image of [Photo by: ABC News]

By Talia Ramos (NEWS CONSORTIUM)

To try to live a healthy life, get a job and save his failing marriage, a 560-pound man decided to embark on a biking journey across the United States. He has already traveled about 90 miles since he started last month and has lost around 60 pounds during the first two ... continue reading


Catholic organization's approach to female reproductive health a 'game changer' Watch

Image of Together with his colleagues, Dr. Thomas Hilgers developed NaPro (Natural Procreative) Technology. In Omaha in 1985, they founded the Pope Paul VI Institute for the Study of Human Reproduction, and in 1999 formally created the Creighton Model FertilityCare System.

By Gabrielle Cubera, CNA EWTN News

With the hope of providing authentic and ethical health care for women, Dr. Thomas Hilgers, creator of Natural Procreative Technology, has worked for decades to establish a medical network that studies, understands, and treats the female fertility cycle. Omaha, ... continue reading


Have scientists found the key to shut off aging? New study with worms finds success Watch

Image of

By Nikky Andres (NEWS CONSORTIUM)

Scientists have uncovered how to switch off the aging process, during a recent study with worms, which could possibly lead to the process being successful in humans. MUNTINLUPA, PHILIPPINES (Catholic Online) - The new study showed that adult cells of worms shortly ... continue reading


New eye drops may soon replace cataract surgery Watch

Image of Vision could cease altogether if cataracts remain untreated. Cataracts cause more blindness worldwide than any other eye condition.

By Catholic Online (NEWS CONSORTIUM)

Inexpensive and easy to administer, a new eye drop may soon make cataract removal surgery obsolete. A frequent bane of existence that afflicts the elderly, the new drops dissolves the clumps of protein that clouds vision. LOS ANGELES, CA (Catholic Online) - Cataract ... continue reading


Superhero DNA desired by pharmaceutical researchers for new drugs Watch

Image of

By Atarah Haely (NEWS CONSORTIUM)

They don't have the ability to fly or come with laser eyes, but there are people who exist today with the "superhero" genes. Similar to the figures portrayed in media, these people have ordinary lives with extraordinary physical abilities because of uncommon biological ... continue reading


Controversial Dr. Death and his 'Destiny machine' set out to help assist the suicide of an entire volunteer audience Watch

Image of

By Talia Ramos (NEWS CONSORTIUM)

Controversial medic known as Dr. Death will try to gas a volunteer audience at the Edinburg Fringe show, which he hosts, with his updated "right-to-die machine" to showcase "a peaceful and reliable means of death." According to reports, he will invite people from the ... continue reading


Human contact with armadillos blamed for surge in leprosy cases in Florida Watch

Image of Floridians are being advised to use caution and not touch the small, cat-sized creatures.

By Catholic Online (NEWS CONSORTIUM)

Increased human contact with armadillos is being blamed for an increase in leprosy cases in Florida. The state usually sees two to 12 cases of leprosy a year. There have been nine cases in 2015 alone, which is higher than average, according to the Florida ... continue reading


4 common reasons for weight-loss failure Watch

Image of

By Talia Ramos (NEWS CONSORTIUM)

Most of us have tried a lot of different diets in pursuit of a healthier body but for some reason most attempts don't work the way we wanted or expected them to. According to Dr. Sally Norton, a weight loss expert, we have to reconsider our entire lifestyle in order ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Daily Readings

Gospel, John 11:19-27
19 and many Jews had come to Martha and Mary to ... Read More

Saint of the Day

Saint of the Day for July 29th, 2015 Image

St. Martha
July 29: "Jesus loved Martha and Mary and Lazarus." This unique ... Read More

Inform, Inspire & Ignite Logo

Find Catholic Online on Facebook and get updates right in your live feed.

Become a fan of Catholic Online on Facebook


Follow Catholic Online on Twitter and get News and Product updates.

Follow us on Twitter